Medicare & Medicaid
On or before September 1, CMS will release the names of the 10 Part D drugs subject to negotiated prices starting in 2026.
The new program would allow for monthly payments over a year.
Select says the plan offerings will increase access to options and services that promote health and wellness.
A strong majority also agrees that future generations will have to pay more or accept reduced benefits.
Episode-based payment incentives must be aligned across other value-based models, CMS says.
HCSC will offer MA and/or Medicare Advantage Prescription Drug plans in more than 82% of counties in the states it serves.
These improvements are likely driven by the continued opioid crisis and the concurrent growth in demand for affordable SUD treatment.
NAACOS, AHIP and AMA have recommendations for interoperability around value-based care.
The funds will help address the issue of qualified applicants being turned away from academic training due to lack of faculty.
Just 44% of MA beneficiaries said they fully understand their plan, while 50% say they "somewhat" understand it.